comscore New leader picked for struggling UH Cancer Center | Honolulu Star-Advertiser
Top News

New leader picked for struggling UH Cancer Center

  • COURTESY UNIVERSITY OF HAWAII

    Dr. Randall F. Holcombe.

The University of Hawaii has selected a renowned colon cancer expert who oversees cancer care for a hospital network in New York City to lead the financially struggling UH Cancer Center — a move that outside groups have suggested could help stabilize and strengthen the research center.

UH is recommending Dr. Randall F. Holcombe, one of four finalists announced in March, as director of the Cancer Center, with a $410,004 annual salary. If approved by the Board of Regents at its monthly meeting Thursday, the appointment would be effective Sept. 1.

The center’s former director, Michele Carbone, who resigned in November 2014 after five years in the post, was paid $412,008 as director. Dr. Jerris Hedges, dean of the John A. Burns School of Medicine, has been serving as interim director.

Holcombe is chief medical officer for cancer for Mount Sinai Health System, which runs seven hospital campuses in the New York City area.

He joined Mount Sinai in September 2010. Within the organization, Holcombe also serves as deputy director for the Tisch Cancer Institute at Mount Sinai and director of ambulatory oncology at The Mount Sinai Hospital. He also is a professor of medicine in the Hematology and Medical Oncology Division at the Icahn School of Medicine at Mount Sinai.

“We are happy to be able to present such an outstanding candidate to the Board of Regents, a candidate who sees the great value of the UH Cancer Center in Hawaii and wants to continue its mission of reducing the burden of cancer in our communities through research, education and improved patient care,” Michael Bruno, UH-Manoa’s vice chancellor for research, said in a statement.

Holcombe received his doctor of medicine from the University of Medicine and Dentistry of New Jersey in 1983. He worked at Louisiana State University School of Medicine as an assistant professor of medicine before joining the University of California-Irvine Medical Center, where he held roles including chief of the Hematology/Oncology Division, director of the Office of Clinical Research and Trials and associate vice chancellor for research.

“He can be instrumental in our efforts to keep the UH Cancer Center (National Cancer Institute)-designated, a distinction that only 69 out of more than 1,600 cancer centers in the US have,” Hedges, the medical school dean, said of Holcombe in a statement. The federal NCI designation gives UH an edge when competing for federal funds and recruiting scientists.

Holcome would be joining UH at a time when university officials and lawmakers continue to disagree over the future of the Cancer Center, which has been overspending revenues and burning through its reserve to stay afloat. Lawmakers rejected the university’s request for an additional $5 million for operations next year, citing the lack of a sustainable business plan.

The center’s financial troubles can be traced back to a faulty business plan that had assumed the university’s share of the state’s cigarette tax would remain constant at $19 million per year. But as fewer people smoke, the tax revenues have dropped to about $14 million annually. Turmoil surrounding the center’s previous leadership and the negative publicity that ensued also affected philanthropy and recruitment of researchers.

Comments (6)

By participating in online discussions you acknowledge that you have agreed to the Terms of Service. An insightful discussion of ideas and viewpoints is encouraged, but comments must be civil and in good taste, with no personal attacks. If your comments are inappropriate, you may be banned from posting. Report comments if you believe they do not follow our guidelines.

Having trouble with comments? Learn more here.

Leave a Reply

  • Nice. I hope he can help the “cancer” of the UH Cancer Center. Thank you to the selection committee for choosing someone with a good track record and “real research” experience and not choosing a nut case who ends up leadership because he/she needs narcissistic attention or needs a job because they are tenured at UH and there is nothing to do with them.

  • Perhaps the Regents have decided on the Consultant’s planned. But they are not not announcing a business plan.

    They seem to be hoping that this new administrator can hold things together while they come up with a new business plan? Is the politics problem with the University and the legislature really resolved with this decision?

  • The new trend is to have several major medical programs located within a major designated campus so academia and real time research and applications can benefit each other. A shining example where public and private funding intersect and are shortening time for new medical discoveries is the SF UCSF Mission Bay Campus. Having an isolated cancer research program in Hawaii is going in the opposite direction. Sad, but closing the program soon is the best option. Wrong place, wrong time.
    https://www.ucsf.edu/about/locations/mission-bay

Click here to see our full coverage of the coronavirus outbreak. Submit your coronavirus news tip.

Be the first to know
Get web push notifications from Star-Advertiser when the next breaking story happens — it's FREE! You just need a supported web browser.
Subscribe for this feature

Scroll Up